# Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)

> **NCT06467981** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 160 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** Retrospective study

## Key facts

- **NCT ID:** NCT06467981
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-02-15
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06467981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06467981, "Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06467981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*